While there is no doubt that CML is caused by the expression of the BCR-ABL1 fusion transcript, genetic heterogenity of the fusion junction might influence disease progression [13]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.